Anti-epileptic drugs induce cutaneous lymphocyte-associated antigen downregulation leading to potential human herpes virus-7 reactivation in clinically asymptomatic patients
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2018 |
---|---|
Erschienen: |
2018 |
Enthalten in: |
Zur Gesamtaufnahme - volume:32 |
---|---|
Enthalten in: |
Journal of the European Academy of Dermatology and Venereology : JEADV - 32(2018), 2 vom: 27. Feb., Seite e41-e43 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Caillot, F [VerfasserIn] |
---|
Links: |
---|
Themen: |
6-sulfo sialyl Lewis X |
---|
Anmerkungen: |
Date Completed 26.08.2019 Date Revised 10.12.2019 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1111/jdv.14493 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM274326140 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM274326140 | ||
003 | DE-627 | ||
005 | 20231225003234.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2018 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1111/jdv.14493 |2 doi | |
028 | 5 | 2 | |a pubmed24n0914.xml |
035 | |a (DE-627)NLM274326140 | ||
035 | |a (NLM)28758263 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Caillot, F |e verfasserin |4 aut | |
245 | 1 | 0 | |a Anti-epileptic drugs induce cutaneous lymphocyte-associated antigen downregulation leading to potential human herpes virus-7 reactivation in clinically asymptomatic patients |
264 | 1 | |c 2018 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 26.08.2019 | ||
500 | |a Date Revised 10.12.2019 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Letter | |
650 | 7 | |a 6-sulfo sialyl Lewis X |2 NLM | |
650 | 7 | |a Anticonvulsants |2 NLM | |
650 | 7 | |a Lewis X Antigen |2 NLM | |
650 | 7 | |a Oligosaccharides |2 NLM | |
650 | 7 | |a Sialyl Lewis X Antigen |2 NLM | |
650 | 7 | |a Valproic Acid |2 NLM | |
650 | 7 | |a 614OI1Z5WI |2 NLM | |
700 | 1 | |a Andrieu, E |e verfasserin |4 aut | |
700 | 1 | |a Houivet, E |e verfasserin |4 aut | |
700 | 1 | |a Duvert-Lehembre, S |e verfasserin |4 aut | |
700 | 1 | |a Calbo, S |e verfasserin |4 aut | |
700 | 1 | |a Sabbah, B |e verfasserin |4 aut | |
700 | 1 | |a Maltete, D |e verfasserin |4 aut | |
700 | 1 | |a Martinaud, O |e verfasserin |4 aut | |
700 | 1 | |a Le Goff, F |e verfasserin |4 aut | |
700 | 1 | |a Malekpour, P |e verfasserin |4 aut | |
700 | 1 | |a Berard, M |e verfasserin |4 aut | |
700 | 1 | |a Rogez, S |e verfasserin |4 aut | |
700 | 1 | |a Joly, P |e verfasserin |4 aut | |
700 | 1 | |a Picard, D |e verfasserin |4 aut | |
700 | 1 | |a Musette, P |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of the European Academy of Dermatology and Venereology : JEADV |d 1997 |g 32(2018), 2 vom: 27. Feb., Seite e41-e43 |w (DE-627)NLM091705932 |x 1468-3083 |7 nnns |
773 | 1 | 8 | |g volume:32 |g year:2018 |g number:2 |g day:27 |g month:02 |g pages:e41-e43 |
856 | 4 | 0 | |u http://dx.doi.org/10.1111/jdv.14493 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 32 |j 2018 |e 2 |b 27 |c 02 |h e41-e43 |